Serum S100A12 in the clinical diagnosis of sepsis-induced myocardial dysfunction: an integrated bioinformatics and clinical data analysis

As an inflammatory biomarker, S100A12 has independent predictive value, and its combination with cardiac enzymes enables the development of an efficient clinical warning model. The study highlights a potential new biomarker and treatment focus that could aid in early detection and management of sepsis-related cardiac injury.